2 Results for "

tumor targeting superantigen

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "tumor targeting superantigen" in MCE Product Catalog:

Cat. No.: HY-P99943
CAS No.: 2367013-69-0
Synonyms: KN-046

Target:  

PD-1/PD-L1 CTLA-4

Research Areas:  

Cancer

Erfonrilimab (KN-046) is a monoclonal antibody targeting PD-L1/CTLA-4. Erfonrilimab blocks the PD-L1 and CTLA-4 pathways, thereby regulating T cell function. Erfonrilimab enhances the secretion of IL-2 in superantigen-stimulated peripheral blood mononuclear cells. Erfonrilimab inhibits tumor growth in xenograft and double gene knock-in mouse models. Erfonrilimab can be used in research related to a variety of advanced solid tumors, including non-small cell lung cancer and nasopharyngeal carcinoma.
loading...
    loading...
Cat. No.: HY-P99035
CAS No.: 1412892-09-1

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology Cancer

Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma .
loading...
    loading...